Bya Cocer Peptides 
omwezi gumu emabega
EBINTU BYONNNA N’AMAWULIRE GW’EBINTU EBIweereddwa KU MUTINDO GUNO BIKOZESEBWA KU KUSASANYA AMAWULIRE N’EBIKOLWA BY’OKUSOMESA.
Ebintu ebiweereddwa ku mukutu guno bigendereddwamu kunoonyereza mu kisenge (in vitro research) byokka. Okunoonyereza mu vitro (Olulattini: *mu ndabirwamu*, ekitegeeza mu bikozesebwa mu ndabirwamu) kukolebwa ebweru w’omubiri gw’omuntu. Ebintu bino si bya ddagala, tebikkiriziddwa kitongole kya Amerika ekivunaanyizibwa ku by’emmere n’eddagala (FDA), era tebirina kukozesebwa kuziyiza, kujjanjaba oba kuwonya mbeera yonna ya bujjanjabi, bulwadde oba bulwadde. Kikugirwa nnyo mu mateeka okuyingiza ebintu bino mu mubiri gw’omuntu oba ebisolo mu ngeri yonna.
Okulambika okutwaliza awamu
Tirzepatid, eddagala eriyiiya, lifunye okufaayo okunene mu by’okujjanjaba ssukaali. Ye nkola ey’emirundi ebiri esoose mu nsi yonna ey’ekirungo ekikwata glucagon-like peptide-1 (GLP-1) n’ekirungo ekikwata insulinotropic polypeptide (GIP) eyeesigama ku glucose. Okuyita mu nkola yaayo ey’enjawulo ey’okukola, ekoppa ebikolwa eby’obutonde ebya GLP-1 ne GIP, n’ewa eky’okulonda ekipya eky’okufuga glucose mu musaayi.
Ekifaananyi 1 Enkola z’okukola kwa Tirzepatid mu mubiri gw’omuntu.
Enkola y’Ekikolwa
Okulungamya okufulumya insulini ne glucagon: Tirzepatid eyongera ku kufulumya insulini n’okukendeeza ku kufulumya glucagon mu ngeri eyeesigama ku glucose. Omuwendo gwa glucose mu musaayi bwe gulinnya, Tirzepatid aleetera obutoffaali bwa pancreatic beta okufulumya insulini ennyingi, bwe kityo ne kyanguya okutwala glucose n’okukozesa n’okukendeeza ku glucose mu musaayi; era kiziyiza okufulumya glucagon, okukendeeza ku glucose afuluma mu kibumba, okwongera okutebenkeza emiwendo gya glucose mu musaayi. Enkola eno ey’okulungamya ey’emitendera ebiri eyamba okukuuma bbalansi ya glucose mu musaayi ekyukakyuka, mu ngeri ennungi n’ekendeeza ku mutindo gwa glucose mu musaayi mu kisiibo n’oluvannyuma lw’okulya.
Okutumbula okukkuta n’okugejja: Eddagala lino liyinza okutumbula okukkuta, ekivaako abalwadde okukendeeza ku mmere gye balya era bwe batyo ne bakendeeza ku mugejjo. Okugejja kikulu nnyo eri abalwadde ba ssukaali ow’ekika eky’okubiri, kubanga omugejjo gutera okukwatagana nnyo n’obuziyiza insulini. Nga ekendeeza ku buzito, Tirzepatid eyamba okulongoosa enkola ya insulini, okufuula omubiri okukola obulungi ku insulini era bwe kityo ne kifuga bulungi emiwendo gya glucose mu musaayi. Okugatta ku ekyo, okugejja kiyamba okukendeeza ku bulabe bw’ebizibu ng’endwadde z’emisuwa mu balwadde ba ssukaali.
Okulwawo okufulumya amazzi mu lubuto: Tirzepatid alwawo okufulumya amazzi mu lubuto, n’ewangaaza ekiseera emmere gy’emala mu lubuto n’okukendeeza ku kuyingira kwayo mu kyenda ekitono, bwe kityo ne kiziyiza ssukaali okulinnya amangu mu musaayi. Ekikolwa kino kiyamba okutebenkeza enkyukakyuka za ssukaali mu musaayi naddala nga kifuga bulungi entikko za ssukaali mu musaayi oluvannyuma lw’okulya, ne kireetawo embeera ennungi ey’okufuga ssukaali mu musaayi mu ngeri ennywevu.
Okulongoosa obubonero bw’enkyukakyuka y’emmere: Ng’oggyeeko ebikosa ssukaali n’obuzito mu musaayi, Tirzepatid era eraga ebikolwa ebirungi mu kulongoosa emiwendo gy’amasavu n’obubonero obulala obulaga enkyukakyuka mu mubiri. Okunoonyereza kulaga nti ayamba okukendeeza ku kolesterol ne triglyceride mu low-density lipoprotein (LDL), okutumbula obulamu bw’enkyukakyuka mu mubiri okutwalira awamu n’okwongera okukendeeza ku bulabe bw’endwadde z’emisuwa mu balwadde ba ssukaali.
Okusaba
Mu kunoonyereza okwamalirizibwa okwa SURPASS ne SURMOUNT okunene okwa Phase III clinical studies, Tirzepatid yalaga obusobozi obw’okufuga glucose mu musaayi obw’ekika ekya waggulu. Bw’ogeraageranya ne placebo, Tirzepatid yakendeeza nnyo ku miwendo gya hemoglobin A1c (HbA1c) ate nga era yalaga ebikolwa ebirungi ennyo mu kugejja. Obulung’amu bwayo busukkulumye ku bwa GLP-1 receptor agonists ezikkirizibwa mu kiseera kino. Mu kugezesebwa okumu, abalwadde abajjanjabwa ne Tirzepatid baafuna okukendeera okunene mu miwendo gya HbA1c n’okugejja okweyoleka, nga kiraga bulungi obulungi bwayo n’okusukkuluma kwayo mu kufuga glycemic n’okuddukanya omugejjo.
Obujjanjabi bwa sukaali ow’ekika eky’okubiri: Ng’ekigatta ku mmere n’okukola dduyiro, Tirzepatid egaba obujjanjabi obulungi eri abalwadde ba sukaali ow’ekika eky’okubiri. Ka kibe nti ekozesebwa ng’eddagala limu oba ng’egattibwa wamu n’eddagala eddala eritta ssukaali, Tirzepatid erongoosa nnyo okufuga sukaali mu musaayi gw’abalwadde.
Mu bufunzi
Mu bufunze, Tirzepatid eraga ebirungi mu kufuga glucose mu musaayi olw’enkola yaayo ey’enjawulo ey’okukola n’okukola obulungi mu kugezesebwa okw’obujjanjabi. Tekoma ku kukendeeza bulungi ku mutindo gwa glucose mu musaayi wabula era ekola kinene mu kuddukanya obuzito n’okulongoosa obubonero bw’enkyukakyuka y’emmere.
Ensonda
[1] Sood A, Kaur P, Syed O, n’abalala. Enkyukakyuka mu kulabirira ssukaali: okulaga obusobozi bwa tirzepatide mu kufuga glycemic n’okusingawo[J]. Omukugu mu kwekenneenya eddagala mu bujjanjabi, 2024, 17 (3): 235-246.DOI: 10.1080 / 17512433.2024.2310070.
[2] Wong E, Cope R, Dima L, n’abalala. Tirzepatid: Ekirungo kya Insulinotropic Polypeptide ekyesigama ku Glucose eky’emirundi ebiri ne Glucagon-Like Peptide-1 Agonist okuddukanya obulwadde bwa sukaali obw’ekika eky’okubiri[J]. Ekitabo ky’Amerika eky’obujjanjabi, 2023,30 (1):e26-e35.DOI:10.1097/MJT.0000000000001588.
[3] Kumar D, Harshidha D, Mousigan M, n’abalala. Okulambika ku Tirzepatid, Obujjanjabi obw’ebigendererwa bibiri ku Ssukaali n’Omugejjo[J]. Ekitabo ky’ensi yonna eky’okunoonyereza okuyiiya n’okukula, 2022,7:983.DOI:10.5281/zenodo.7420605.
[4] Chavda V. P., Ajabiya J., Teli D., n’abalala. Tirzepatid, Omulembe Omupya ogw’obujjanjabi obw’ebigendererwa bibiri ku ssukaali n’omugejjo: Okuddamu okwetegereza okutono[J]. Molekyulu, 2022,27 (13).DOI: 10.3390 / molekyu27134315.
[5] Forzano I, Varzideh F, Avvisato R, n’abalala. Tirzepatid: Okulongoosa mu nteekateeka[J]. Ekitabo ky’ensi yonna ekya Sayansi wa Molekyulu, 2022,23 (23).DOI:10.3390/ijms232314631.
Ekintu ekiriwo okukozesebwa mu kunoonyereza kwokka:
